Stage of Breast Cancer Progression Influences Cellular Response to Activation of the WNT/Planar Cell Polarity Pathway

Scientific Reports

Volumn 3, Issue , 2014, Pages

  MacMillan, Connor D ^a,b   Leong, Hon S ^a,b   Dales, David W ^b   Robertson, Amy E ^a,b   Lewis, John D ^c   Chambers, Ann F ^a,b   Tuck, Alan B ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYCLOOXYGENASE 2; MEMBRANE PROTEIN; MESSENGER RNA; MMP3 PROTEIN, HUMAN; ONCOPROTEIN; PTGS2 PROTEIN, HUMAN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, HUMAN; SMALL INTERFERING RNA; STROMELYSIN; TRANSCRIPTION FACTOR AP 1; VANGL1 PROTEIN, HUMAN; WNT PROTEIN; WNT5A PROTEIN, HUMAN;

BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; CELL POLARITY; DISEASE COURSE; FEMALE; GENETICS; HUMAN; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION; WNT SIGNALING PATHWAY;

BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; CYCLOOXYGENASE 2; DISEASE PROGRESSION; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 3; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84928684757     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06315     Document Type: Article

References (48)

1. Page, D. L., Dupont, W. D., Rogers, L. W. & Rados, M. S. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55, 2698-2708, doi:10.1097/00006534-198604000-00059 (1985).
2. Page, D. L. & Dupont, W. D. Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res Treat 28, 157-166, doi:10.1007/BF00666428 (1993).
3. Lakhani, S. R., Collins, N., Stratton, M. R. & Sloane, J. P. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48, 611-615, doi:10.1136/jcp.48.7.611 (1995).
4. Allred, D. C., Mohsin, S. K. & Fuqua, S. A. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8, 47-61, doi:10.1677/erc.0.0080047 (2001).
5. Allred, D. C. et al. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14, 370-378, doi:10.1158/1078-0432.CCR-07-1127 (2008).
6. Arpino, G., Laucirica, R. & Elledge, R. M. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 143, 446-457 (2005).
7. Souter, L. H. et al. Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patterns. Lab Invest 90, 1247-1258, doi:10.1038/labinvest.2010.97 (2010).
8. Pukrop, T. et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A 103, 5454-5459, doi:10.1073/pnas.0509703103 (2006).
9. Weeraratna, A. T. et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1, 279-288, doi:10.1016/S1535-6108(02)00045-4 (2002).
10. Kurayoshi, M. et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66, 10439-10448, doi:10.1158/0008-5472.CAN-06-2359 (2006).
11. Medina, A., Reintsch, W. & Steinbeisser, H. Xenopus frizzled 7 can act in canonical and non-canonical Wnt signaling pathways: implications on early patterning and morphogenesis. Mech Dev 92, 227-237 (2000).
12. Kinoshita, N., Iioka, H., Miyakoshi, A. & Ueno, N. PKC delta is essential for Dishevelled function in a noncanonical Wnt pathway that regulates Xenopus convergent extension movements. Genes Dev 17, 1663-1676, doi:10.1101/gad.1101303 (2003).
13. Tanegashima, K., Zhao, H. & Dawid, I. B. WGEF activates Rho in the Wnt-PCP pathway and controls convergent extension in Xenopus gastrulation. EMBO J 27, 606-617, doi:10.1038/emboj.2008.9 (2008).
14. Vincan, E., Swain, R. K., Brabletz, T. & Steinbeisser, H. Frizzled7 dictates embryonic morphogenesis: implications for colorectal cancer progression. Front Biosci 12, 4558-4567 (2007).
15. Ueno, K. et al. Frizzled-7 as a potential therapeutic target in colorectal cancer. Neoplasia 10, 697-705 (2008).
16. Merle, P. et al. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 127, 1110-1122 (2004).
17. Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5, 367-377, doi:10.1016/S1534-5807(03)00266-1 (2003).
18. Yagyu, R.etal. Isolation and characterizationofanovel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. Int J Oncol 20, 1173-1178 (2002).
19. Cho, S. B. et al. KITENIN is associated with activation of AP-1 target genes via MAPK cascades signaling in human hepatocellular carcinoma progression. Oncology research 19, 115-123, doi:10.3727/096504011X12935427587722 (2011).
20. Lee, J. H. et al. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 64, 4235-4243, doi:10.1158/0008-5472.CAN-04-0275 (2004).
21. Lee, J. K. et al. KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model. FEBS Lett 583, 711-717, doi:10.1016/j.febslet.2009.01.014 (2009).
22. Lee, J. H. et al. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein. Cancer Res 65, 8993-9003, doi:10.1158/0008-5472.CAN-05-0590 (2005).
23. Kho, D. H. et al. KITENIN recruits Dishevelled/PKC delta to form a functional complex and controls the migration and invasiveness of colorectal cancer cells. Gut 58, 509-519, doi:10.1136/gut.2008.150938 (2009).
24. Olson, D. J. & Gibo, D. M. Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation. Exp Cell Res 241, 134-141, doi:10.1006/excr.1998.4030 (1998).
25. Liang, H. et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4, 349-360, doi:10.1016/S1535-6108(03)00268-X (2003).
26. Kremenevskaja, N. et al. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24, 2144-2154, doi:10.1038/sj.onc.1208370 (2005).
27. Leris, A. C., Roberts, T. R., Jiang, W. G., Newbold, R. F. & Mokbel, K. WNT5A expression in human breast cancer. Anticancer research 25, 731-734 (2005).
28. Ying, J. et al. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 110, 4130-4132, doi:10.1182/blood-2007-06-094870 (2007).
29. Ying, J. et al. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 14, 55-61, doi:10.1158/1078-0432.CCR-07-1644 (2008).
30. Liu, X. H. et al. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. Dig Liver Dis 40, 560-567, doi:10.1016/j.dld.2007.12.011 (2008).
31. Lee, G. Y., Kenny, P. A., Lee, E. H. & Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4, 359-365, doi:10.1038/nmeth1015 (2007).
32. Hebner, C., Weaver, V. M. & Debnath, J. Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures. Annu Rev Pathol 3, 313-339, doi:10.1146/annurev.pathmechdis.3.121806.151526 (2008).
33. Arpaia, E. et al. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk. Oncogene 31, 884-896, doi:10.1038/onc.2011.288 (2012).
34. Cvetkovic, D. et al. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells. Endocrinology 154, 1999-2014, doi:10.1210/en.2012-2164 (2013).
35. Leong, H. S., Chambers, A. F. & Lewis, J. D. Assessing cancer cell migration and metastatic growth in vivo in the chick embryo using fluorescence intravital imaging. Methods Mol Biol 872, 1-14, doi:10.1007/978-1-61779-797-2-1 (2012).
36. Leong, H. S. et al. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nature protocols 5, 1406-1417, doi:10.1038/nprot.2010.103 (2010).
37. Lee, S. et al. Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression. Pathology international 61, 210-220, doi:10.1111/j.1440-1827.2011.02646.x (2011).
38. Ryu, H. S. et al. KITENIN is associated with tumor progression in human gastric cancer. Anticancer research 30, 3479-3486 (2010).
39. Chang, C. & Werb, Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends in cell biology 11, S37-43, doi:10.1016/S0962-8924(01)02122-5 (2001).
40. Gauthier, M. L. et al. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 12, 479-491, doi:10.1016/j.ccr.2007.10.017 (2007).
41. Kerlikowske, K. et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 102, 627-637, doi:10.1093/jnci/djq101 (2010).
42. Radisky, D. C. et al. p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia. Cancer Prev Res (Phila) 4, 1953-1960, doi:10.1158/1940-6207.CAPR-11-0282 (2011).
43. Ren, D., Minami, Y. & Nishita, M. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Genes Cells 16, 304-315, doi:10.1111/j.1365-2443.2011.01487.x (2011).
44. Lai, S. S. et al. Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE. Cancer Genet 205, 552-562, doi:10.1016/j.cancergen.2012.09.002 (2012).
45. Habu, M. et al. Ryk is essential for Wnt-5a-dependent invasiveness in human glioma. J Biochem 156, 29-38, doi:10.1093/jb/mvu015 (2014).
46. Band, V. et al. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 50, 7351-7357 (1990).
47. Moffat, J. et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298, doi:10.1016/j.cell.2006.01.040 (2006).
48. Debnath, J., Muthuswamy, S. K. & Brugge, J. S.Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268, doi:10.1016/S1046-2023(03)00032-X (2003).